Trials / Completed
CompletedNCT01429857
Prognostic Relevance of High-sensitivity Troponin in Patients With Acute Decompensated Heart Failure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 304 (actual)
- Sponsor
- University Hospital, Saarland · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the prognostic value of admission high-sensitivity troponin in patients with acute decompensated heart failure.
Detailed description
Patients admitted for acute decompensated heart failure are included in the study. After gaining informed consent, concentrations of high-sensitivity troponin on admission and on discharge are assessed. 6 months after discharged, the incidence of clinical endpoint (mortality of all cause and of cardiovascular cause, hospitalization) is assessed by telephone contact to the patient and/or the physician. The aim of the study is to investigate the prognostic value of high-sensitivity troponin concentration for predicting death and re-hospitalization.
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2011-09-07
- Last updated
- 2013-06-14
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01429857. Inclusion in this directory is not an endorsement.